Orforglipron vs Dapagliflozin in Type 2 Diabetes: What the ACHIEVE-2 Trial Found 11th July 2026 by Living Diabetes Editorial ACHIEVE-2 compared oral orforglipron with dapagliflozin in adults with type 2 diabetes. Learn about HbA1c, weight, side effects, and study limits.
Insulin cost caps help some commercially insured adults, but many insulin users remain unprotected 1st July 20261st July 2026 by Living Diabetes Editorial New Diabetes Care research explains why state insulin cost caps help some people, but leave many insulin users outside the protections.
Intermittent Fasting With Diabetes: Safety Questions Before You Start 6th June 202626th March 2026 by Living Diabetes Editorial Intermittent fasting with diabetes can change low-blood-sugar and medicine risk. Learn what to ask before trying it.
Statins and Diabetes: Benefits, Risks, and Questions to Ask 3rd June 202625th March 2026 by Living Diabetes Editorial Team Statins may slightly affect diabetes risk, but for many people with diabetes their heart-protection benefits are more important.
Low Testosterone and Diabetes: What to Ask Before Treatment 6th June 202615th March 2026 by Living Diabetes Editorial Low testosterone treatment should follow confirmed testing and a safety review, not supplement hype. Learn what to ask.
When Diabetes Medications Need Review: What to Check 6th June 202618th November 2025 by Living Diabetes Editorial Team If diabetes medicines are not meeting goals, the answer may be review, not blame. Learn what to check before changing treatment.
Diabetes Medications Explained: Options, Benefits, and Safety 6th June 202617th November 2025 by Living Diabetes Editorial Team Diabetes medicines work in different ways. Learn common options, why treatment is individualized, and what safety questions to ask.
